Serial Cancer Development Three Times in a Patient with Fanconi Anemia

Serial Cancer Development Three Times in a Patient with Fanconi Anemia

Fanconi anemia (FA) is characterized clinically by bone marrow failure, congenital malformations, sensitivity to DNA cross-linking agents, and increased risk of malignancy. Hematological cancer is the best-described malignancy in patients with FA, but the susceptibility to the development of solid t...

Full description

Bibliographic Details
Main Authors: Katsuya Yanagisawa, Toshimichi Horiuchi, Akemi Matsuo, Hiroshi Kuraishi, Hidetoshi Satomi, Ichiro Ito, Takuro Noguchi, Nodoka Sekiguchi, Shintaro Kanda, Tomonobu Koizumi
Format: Article
Language:English
Published: Karger Publishers 2021-08-01
Series:Case Reports in Oncology
Subjects:
squamous cell carcinoma
radiotherapy
secondary malignancy
lung cancer
hematopoietic stem cell transplantation
fanconi anemia
Online Access:https://www.karger.com/Article/FullText/518076

Internet

https://www.karger.com/Article/FullText/518076

Similar Items